Kangning Hospital Addresses Public Shareholding Compliance Issue and Launches Brain-Computer Interface Clinical Translation Center

Economic Observer NetworkWenzhou Kangning Hospital’s recent core focus has centered on compliance with public float requirements and business collaborations, leading to a range-bound decline in its stock price.

Recent Events:

According to the announcement released by the company on June 3, its public float is approximately 24.11%, which has fallen below the minimum requirement of 25% stipulated by the Hong Kong Stock Exchange.. The company expects to restore compliance by September 2026 at the latest and emphasizes that daily business operations are proceeding as usual. This matter may affect stock liquidity and has become the primary focus of recent market attention. From May 29 to 30,Xiangyu MedicalAnnounced the joint establishment of the “Clinical Translation Center for Brain-Computer Interface Neuromodulation in Psychiatric and Psychological Disorders” with Kangning Hospital Affiliated to Ningbo University. This collaboration aims to accelerate the clinical translation of brain-computer interface technology in the field of psychiatric and psychological disorders, representing an exploration of frontier technology applications.

Recent Stock Performance:

According to the internal database, the company's stock price fell by 6.79% during the period from May 29 to June 5, hitting a low of HK$8.20. From June 3 to 4, capital flow data indicated net outflows from retail investors, with no participation from institutional investors. Trading on June 5 was extremely thin, with only 100 shares traded throughout the day, and the closing price remained unchanged at HK$8.38.

In the near term, key attention should be paid to the measures taken by the company to restore its public float and their progress, as this is a critical compliance issue affecting its listing status on the Hong Kong Stock Exchange. Meanwhile, industry-academia-research collaboration in the field of brain-computer interfaces represents an exploratory direction for its long-term business development.

The above content is compiled based on public information and does not constitute investment advice.